Inventor · disambiguated record
Dandan Huang
Also filed as: HUANG DANDAN
3 granted patents·7 pending applications·1 citations·filing 2016–2022
46Inventor score
Files withBIO THERA SOLUTIONS LTD2CONOPCO INC DBA UNILEVER2NANJING CHIA TAI TIANQING PHARMACEUTICAL CO LTD2NANJING SANHOME PHARMACEUTICAL CO LTD2CONOPCO INC1
Top patents by PatentIndex Score
10 records- 0166US12215084B22(1H)-pyridinones and their use to treat inflammatory conditionsCONOPCO INC·Filed 2020·Granted Feb 4, 2025·0 cites·11 claims
- 0262US10077258B2Substituted pyrimidine compounds as phosphatidylinositol 3-kinase delta inhibitor and use thereofNANJING SANHOME PHARMACEUTICAL CO LTD·Filed 2016·Granted Sep 18, 2018·1 cites·17 claims
- 0352US2025186444A1Methionine adenosyltransferase 2a heterocyclic inhibitorNANJING CHIA TAI TIANQING PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0450US2023203164A1Anti-ctla-4 monoclonal antibody, preparation method therefor, and application thereofBIO THERA SOLUTIONS LTD·Filed 2020·Application pending·0 cites
- 0550US2024287063A1Methionine adenosyltransferase 2a inhibitorNANJING CHIA TAI TIANQING PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0649US2024050358A1Personal care compositionCONOPCO INC DBA UNILEVER·Filed 2021·Application pending·0 cites
- 0746US2023338526A1Anti-cd20 antibody formulation and use of anti-cd20 antibody for treatment of cd20 positive diseasesBIO THERA SOLUTIONS LTD·Filed 2020·Application pending·0 cites
- 0845US2021038668A1Traditional chinese medicine composition for preventing and/or treating ischemic reperfusion injuryTASLY PHARMACEUTICAL GROUP CO·Filed 2019·Application pending·0 cites
- 0945US2022401352A1A cosmetic compositionCONOPCO INC DBA UNILEVER·Filed 2020·Application pending·0 cites
- 1035US10961222B2Chemical compound of isocitrate dehydrogenase inhibitor, and application thereofNANJING SANHOME PHARMACEUTICAL CO LTD·Filed 2017·Granted Mar 30, 2021·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Dandan Huang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →